Vitae Pharmaceuticals Jumps 158% on Allergan plc Deal

Allergan plc (AGN) has agreed to buy Vitae Pharmaceuticals Inc (VTAE) for nearly $640 million

Sep 14, 2016 at 10:33 AM
facebook twitter linkedin


Shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE) have absolutely blown up, after Allergan plc Ordinary Shares (NYSE:AGN) agreed to buy the drugmaker for roughly $640 million in cash, or $21 per share. After being halted in pre-market action, VTAE is now the top percentage gainer on the Nasdaq, more than 158% higher at $20.91 -- fresh off a new annual high of $20.93 -- while AGN has advanced 2.6% at $246.45.

Suffice it to say, VTAE short sellers have gotten toasted. While some of these bears got out in the nick of time -- short interest on the stock fell nearly 10% in the latest report period -- a still-considerable 6.5% of its float is dedicated to short interest. By contrast, five of six analysts rated the shares a "strong buy" heading into today -- and traders who followed their advice are being handsomely rewarded.

The brokerage bunch has also been high on AGN. Eighty percent of analysts tracking the stock consider it worthy of a "buy" or better endorsement, with not a single "sell" opinion to be found. Likewise, options traders have been wagering on upside for the shares. AGN's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is 2.29, near the top one-fifth of all readings taken in the prior year.

That said, Allergan plc Ordinary Shares (NYSE:AGN) hasn't fared nearly as well on the charts as Vitae Pharmaceuticals Inc (NASDAQ:VTAE). Despite sharp gains this morning, the former stock has shed more than 21% year-to-date. Plus, AGN's formerly supportive 50-day moving average looks like it may be switching roles to act as resistance.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

 

 

These investors are using the market's volatility to their advantage and scoring triple-digit gains on many of their trades.

Even in today's sideways bear market, this trading strategy has continued to provide consistency and profitability to a small group of investors. By using this approach, these traders are removing directional risk and still hitting triple-digit returns. If you want access to this strategy, and lower risk with higher returns sounds good to you, then don't wait another minute.

Join us now to receive our next trades the moment they come out!

 

Common mistakes options traders make
 


 


 
Special Offers from Schaeffer's Trading Partners